Clinical Trial Update: FOLFOXIRI With or Without Cetuximab as First-line Treatment of Patients With Non-resectable Liver - Only Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FOLFOXIRI with or without cetuximab as first-line treatment for non-resectable liver-only metastatic colorectal cancer; completed trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• FOLFOXIRI (folinic acid (leucovorin), fluorouracil (5-FU), oxaliplatin, irinotecan)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED